Long Island University

09/24/2026 | News release | Archived content

World Renowned Cancer Expert Leads International Research Platform

Dr. Nabil Hajji, a research scientist at the Dassault Systèmes Center of Excellence at LIU, is directing directing the Translational Systems Medicine Platform for Brain Tumors, a multidisciplinary initiative to develop new biomarkers, therapies, and personalized medicine for patients with brain tumors. Hajji is a world-renowned expert in the field of oncology, recognized for establishing the mechanism underlying the resistance of classical antitumor treatments in several types of cancer.

Long Island University published this content on September 24, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 13, 2026 at 21:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]